We are live on
!
Find out more
FSA
Franklin Street Advisors Portfolio holdings
AUM
$1.79B
1-Year Est. Return
28.1%
This Fund
S&P 500
This Quarter
Est. Return
+13.57%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$718M
AUM Growth
+$86.2M
(+14%)
Cap. Flow
+$9.42M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
29.88%
Holding
176
New
20
Increased
50
Reduced
57
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$9.62M |
| 2 |
Intel
INTC
|
+$8.32M |
| 3 |
AT&T
T
|
+$7.61M |
| 4 |
Blackrock
BLK
|
+$7.05M |
| 5 |
Procter & Gamble
PG
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$8.03M |
| 2 |
CVS Health
CVS
|
+$7.39M |
| 3 |
Lockheed Martin
LMT
|
+$7.14M |
| 4 |
MetLife
MET
|
+$6.27M |
| 5 |
Tapestry
TPR
|
+$3.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.69% |
| 2 | Financials | 15.72% |
| 3 | Healthcare | 14.23% |
| 4 | Consumer Discretionary | 12.52% |
| 5 | Consumer Staples | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVLN
151
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $57K | 0.01% |
46,000
| – | – |
|
152
Rigel Pharmaceuticals
RIGL
$693M
| $53K | 0.01% |
2,050
| – | – |
|
|
MLNT
153
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $48K | 0.01% |
13,590
| – | – |
|
|
BLCM
154
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $38K | 0.01% |
1,142
-4,000
| -78% | -$134K |
|
155
Clorox
CLX
$11.9B
| – | – |
-7,681
| Closed | -$1.18M |
|
|
156
CVS Health
CVS
$134B
| – | – |
-112,784
| Closed | -$7.39M |
|
157
Quest Diagnostics
DGX
$25.6B
| – | – |
-2,428
| Closed | -$202K |
|
158
Eli Lilly
LLY
$1,000B
| – | – |
-2,563
| Closed | -$297K |
|
159
Union Pacific
UNP
$173B
| – | – |
-2,151
| Closed | -$297K |
|
|
ADXS
160
DELISTED
Advaxis Inc
ADXS
| – | – |
-7,320
| Closed | -$21K |
|
|
TFCF
161
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| – | – |
-5,025
| Closed | -$240K |
|
|
SCG
162
DELISTED
Scana
SCG
| – | – |
-5,180
| Closed | -$248K |
|
|
CWBS
163
DELISTED
COMMONWEALTH BANKSHARES INC VA
CWBS
| $0 | ﹤0.01% |
11,761
| – | – |
|
Similar funds
CIM
BP
KPM
BFG
RHJA
EFS
GC
OAM
Franklin Street Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Franklin Street Advisors held 176 positions worth $718M, up 14% from $632M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Franklin Street Advisors's Q1 2019 filing shows 20 new, 50 increased, 57 reduced and 10 closed positions. Its largest new stake was Constellation Brands: 57,119 shares worth $10M. The largest sale was Coca-Cola, an estimated $8.03M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Franklin Street Advisors's largest Q1 2019 buy was Constellation Brands: 57,119 shares worth $10M.
- Franklin Street Advisors added most to Intel in Q1 2019, an estimated $8.32M increase.
- Franklin Street Advisors's biggest Q1 2019 reduction was Coca-Cola, cutting an estimated $8.03M.
- Franklin Street Advisors fully exited CVS Health in Q1 2019, selling an estimated $7.39M.
- Franklin Street Advisors's ten largest holdings make up 30% of its $718M portfolio in Q1 2019.
- Franklin Street Advisors opened 20 new positions and closed 10 in Q1 2019.
- Franklin Street Advisors's portfolio value rose 14% quarter-over-quarter to $718M.
Based on Franklin Street Advisors's 13F filing for Q1 2019, filed 14 May 2019.